Ownership and insider activity for IQVIA Holdings Inc. (IQV): recent transactions by executives and directors. Track how corporate insiders are trading the stock.
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
Price
| Price | $267.33 (closing price, October 30, 2026) |
| Market Cap | $44.1B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-02 | Berkshire James G. | M-Exempt | 5,381 | $709K |
| 2026-09-02 | Berkshire James G. | S-Sale | 2,668 | $697K |
| 2026-09-02 | Berkshire James G. | D-Return | 2,713 | $710K |
| 2026-09-02 | Berkshire James G. | M-Exempt | 5,381 | $709K |
| 2026-08-03 | STAUB W RICHARD | S-Sale | 5,500 | $1.3M |
| 2026-07-31 | Patel Bhavik | S-Sale | 1,855 | $436K |
| 2026-07-29 | Sherbet Eric | S-Sale | 5,000 | $1.2M |
| 2026-07-29 | Cherofsky Keriann | S-Sale | 558 | $137K |
| 2026-07-29 | BOUSBIB ARI | M-Exempt | 156,206 | $12.2M |
| 2026-07-29 | BOUSBIB ARI | S-Sale | 4,465 | $1.1M |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.20B | $959.0M | $891.0M | $837.0M | $1.81B | $1.37B | $1.22B | $1.38B | $1.70B | $1.98B |
| Short-term Investments | $40.0M | $46.0M | $47.0M | $62.0M | $88.0M | $111.0M | $93.0M | $120.0M | $141.0M | $161.0M |
| Receivables | $1.74B | $2.14B | $2.46B | $2.64B | $2.47B | $2.61B | $2.96B | $3.41B | $3.24B | $3.43B |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $3.34B | $3.55B | $3.87B | $4.13B | $5.09B | $4.76B | $4.98B | $5.60B | $5.83B | $6.25B |
| Property, Plant & Equipment | $406.0M | $440.0M | $434.0M | $954.0M | $953.0M | $903.0M | $863.0M | $819.0M | $773.0M | $823.0M |
| Goodwill | $10.73B | $11.85B | $11.80B | $12.16B | $12.65B | $13.30B | $13.92B | $14.57B | $14.71B | $16.62B |
| Intangible Assets | $6.39B | $6.59B | $5.95B | $5.51B | $5.21B | $4.94B | $4.82B | $4.84B | $4.50B | $4.96B |
| Total Assets | $21.21B | $22.74B | $22.55B | $23.25B | $24.56B | $24.69B | $25.34B | $26.68B | $26.90B | $29.94B |
| Accounts Payable | $250.0M | $322.0M | $437.0M | $2.51B | $581.0M | $621.0M | $645.0M | $709.0M | $736.0M | $3.75B |
| Short-term Debt | $92.0M | $103.0M | $100.0M | $100.0M | $149.0M | $91.0M | $152.0M | $718.0M | $1.15B | $1.84B |
| Total Current Liabilities | $2.71B | $2.90B | $3.53B | $3.94B | $4.56B | $5.24B | $5.58B | $6.49B | $6.96B | $8.34B |
| Long-term Debt | $7.11B | $10.12B | $10.91B | $11.54B | $12.38B | $12.03B | $12.60B | $12.96B | $12.84B | $14.11B |
| Total Liabilities | $12.35B | $14.38B | $15.60B | $16.99B | $18.28B | $18.65B | $19.57B | $20.57B | $20.83B | $23.31B |
| Retained Earnings | -$399.0M | $655.0M | $807.0M | $998.0M | $1.28B | $2.24B | $3.33B | $4.69B | $6.07B | $7.42B |
| Total Equity | $8.63B | $8.11B | $6.71B | $6.00B | $6.00B | $6.04B | $5.76B | $6.11B | $6.07B | $6.50B |
| Total Debt | $7.20B | $10.22B | $11.01B | $12.04B | $12.90B | $12.44B | $13.01B | $13.90B | $14.16B | $16.17B |
| Net Debt | $5.96B | $9.22B | $10.07B | $11.14B | $11.00B | $10.96B | $11.70B | $12.40B | $12.31B | $14.03B |
| Working Capital | $632.0M | $650.0M | $340.0M | $181.0M | $532.0M | -$478.0M | -$597.0M | -$895.0M | -$1.13B | -$2.09B |
Financial Health
| Debt / Equity | 2.45 |
| Current Ratio | 0.83 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 2.06 |
Profitability
| Return on Equity | 21.82% |
| Return on Invested Capital | 8.20% |
| Return on Assets | 4.57% |
| Gross Margin | 26.46% |
| Operating Margin | 13.42% |
| Net Margin | 8.05% |
Related companies: MEDP · ICLR · TEM · VEEV · CRL
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of IQV: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks